Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Amortizatization of Intangibles (2024 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 2 years of Amortizatization of Intangibles data on record, last reported at $65000.0 in Q1 2025.

  • For Q1 2025, Amortizatization of Intangibles fell 78.48% year-over-year to $65000.0; the TTM value through Sep 2025 reached $265000.0, changed N/A, while the annual FY2024 figure was $840000.0, N/A changed from the prior year.
  • Amortizatization of Intangibles reached $65000.0 in Q1 2025 per TNXP's latest filing, down from $200000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $302000.0 in Q1 2024 and bottomed at $65000.0 in Q1 2025.